Dr. Goodman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-392-3681Fax+1 352-392-9887
Education & Training
- Yale-New Haven Medical CenterResidency, Psychiatry, 1981 - 1986
- Boston University School of MedicineClass of 1981
Certifications & Licensure
- MT State Medical License 2012 - 2026
- NY State Medical License 2009 - 2026
- FL State Medical License 1997 - 2025
- TX State Medical License 2018 - 2025
- CT State Medical License 1983 - 1998
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Treatment of Obsessive-Compulsive Disorder Start of enrollment: 1992 Sep 01
- Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder Start of enrollment: 2008 Mar 01
- Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 136 citationsA randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedoniaAndrew D. Krystal, Diego A. Pizzagalli, Moria J. Smoski, Sanjay J. Mathew, John I. Nurnberger
Nature Medicine. 2020-03-30 - 208 citationsSpecificity of Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder: Comparison of Fluvoxamine and DesipramineWayne K. Goodman, Lawrence H. Price, Pedro L. Delgado, Joseph Palumbo, John H. Krystal
Archives of General Psychiatry. 1990-06-01 - 35 citationsThe Case for Adaptive Neuromodulation to Treat Severe Intractable Mental Disorders.Nicole R. Provenza, Evan Matteson, Anusha Allawala, Adriel Barrios-Anderson, Sameer A. Sheth
Frontiers in Neuroscience. 2019-02-26
Journal Articles
- High-Dose Ondansetron Reduces Activation of Interoceptive and Sensorimotor Brain RegionsEvan Leibu, Wayne K Goodman, James W Murrough, Barbara J Coffey, Nature
Press Mentions
- Baylor Receives Grant to Study DBS of Treatment-Resistant Bipolar DepressionOctober 17th, 2024
- Access to Deep Brain Stimulation to Treat Severe OCD Is Impeded, Experts SayJuly 18th, 2022
- Could Depression Be Cured? These Houston Doctors Think so — and They're Getting ResultsFebruary 7th, 2022
- Join now to see all
Grant Support
- Pilot Study Of DBS For Treatment-Refractory OCDNational Center For Research Resources2004–2008
- Ssri-Induced Activation Syndrome In Pediatric OCDNational Institute Of Mental Health2006
- Prospective Study Of 'Pandas'National Institute Of Mental Health2002–2005
- Pilot Study Of DBS For Treatment-Refractory OCDNational Institute Of Mental Health2002–2004
- Neurobiology And Treatment Of OCDNational Institute Of Mental Health1997–1999
- Antigen D8/17 As A Marker For Childhood Onset Ocd/TsNational Institute Of Mental Health1997–1999
- Acute Tryptophan Depletion In Medication Remitted Obsessive Compulsive DisorderNational Center For Research Resources1996–1999
- Neurobiology/Treatment Of Obsessive Compulsive DisorderNational Institute Of Mental Health1993–1994
- Neurobiology/Treatment Of Obsessive Compulsive DisorderNational Institute Of Mental Health1992–1993
Professional Memberships
- Member
External Links
- MSSM Psychiatryhttp://icahn.mssm.edu/departments-and-institutes/psychiatry
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: